Global Trust Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.9K	Hold	60	–	–	0.01%	318
2025 Q4	$23.9K	Hold	60	–	–	0.01%	286
2025 Q3	$27.4K	Hold	60	–	–	0.01%	318
2025 Q2	$19.6K	Sell	60 -62	-51%	-$17.2K	0.01%	335
2025 Q1	$32.9K	Hold	122	–	–	0.02%	275
2024 Q4	$28.7K	Hold	122	–	–	0.01%	330
2024 Q3	$33.6K	Hold	122	–	–	0.01%	309
2024 Q2	$29.6K	Hold	122	–	–	0.01%	294
2024 Q1	$18.2K	Hold	122	–	–	0.01%	324
2023 Q4	$23.4K	Hold	122	–	–	0.01%	291
2023 Q3	$21.6K	Hold	122	–	–	0.01%	289
2023 Q2	$23.2K	Hold	122	–	–	0.01%	285
2023 Q1	$24.4K	Hold	122	–	–	0.01%	266
2022 Q4	$29K	Hold	122	–	–	0.01%	248
2022 Q3	$24K	Hold	122	–	–	0.01%	263
2022 Q2	$18K	Hold	122	–	–	0.01%	287
2022 Q1	$20K	Hold	122	–	–	0.01%	332
2021 Q4	$21K	Sell	122 -13	-10%	-$2.42K	0.01%	311
2021 Q3	$25K	Hold	135	–	–	0.01%	277
2021 Q2	$23K	Hold	135	–	–	0.01%	285
2021 Q1	$19K	Buy	+135	New	+$20.3K	0.01%	262